Quick Order Cart

Cat. No. ARG27566

HNRNPR Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

CRISPR/Cas9-edited polyclonal HNRNPR knockout HAP1 cells provide a loss-of-function model for studying the RNA-binding protein HNRNPR, which assembles with SMN and FMRP into neuronal RNA transport granules to regulate axonal mRNA localization and local translation. The HAP1 cell line??s near-haploid, adherent fibroblast-like background is ideal for functional genomics screens. Applications include investigation of RNA granule dynamics, mRNA trafficking, and translational regulation in neurological disease models, using techniques such as RNA immunoprecipitation and RNA-seq.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    HNRNPR

    Gene Identifier

    NCBI Gene ID 10236

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The HNRNPR Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the HNRNPR gene in human near-haploid HAP1 cells. This heterogeneous pool of edited cells carries targeted disruptions of HNRNPR, enabling robust functional investigation of this RNA-binding protein without the need for single-cell cloning. The product is well suited for experiments requiring a polyclonal knockout model that maintains genetic diversity while abrogating HNRNPR expression across the population.

The HAP1 cell line is a human near-haploid, fibroblast-like cell line derived from the KBM-7 chronic myeloid leukemia cell line. Its adherent growth and near-haploid karyotype simplify genetic manipulation and interpretation of knockout phenotypes, as the presence of a single gene copy per cell minimizes confounding effects from genetic redundancy. These characteristics establish HAP1 as a versatile platform for functional genomics, high-throughput genetic screens, and mechanistic studies in a human cell context.

HNRNPR encodes a heterogeneous nuclear ribonucleoprotein that functions as an RNA-binding protein, playing a critical role in mRNA processing, axonal transport, and local translation regulation, particularly in neurons. HNRNPR interacts with SMN, FMRP, STAU1, and the motor protein KIF5A to assemble neuronal RNA transport granules that mediate the trafficking of specific mRNA targets, including ACTB and GAP43, along microtubules. Its activity is regulated by cellular stress signals such as oxidative stress, and it contributes to translational control at synapses, thereby influencing neuronal development and plasticity. Disruption of HNRNPR perturbs these complexes and downstream pathways, offering a direct route to dissect its mechanistic contributions.

Although HAP1 cells are not of neuronal origin, their near-haploid background and robust growth make them an ideal reductionist model to dissect the fundamental cell biology of HNRNPR, including its roles in RNA granule assembly, mRNA transport, and translation regulation. This polyclonal knockout pool enables researchers to investigate loss-of-function effects in a simplified genetic system, facilitating studies of RNA?Cprotein interactions, stress granule dynamics, and global transcriptomic changes without the complexity of diploid or neuronal systems. The knockout model is especially valuable for linking HNRNPR-dependent mechanisms to broader cellular RNA processing pathways.

This cell population supports a diverse range of applications, including functional genomics screens to identify modulators of mRNA trafficking, mechanistic studies of RNA granule composition using immunoprecipitation and CLIP-seq, and transcriptome-wide analysis via RNA-seq. Routine assays such as western blotting and RT-qPCR confirm knockout efficiency, while immunofluorescence and live-cell imaging can assess perturbations in RNA granule localization and dynamics. The cells also enable functional rescue experiments to validate HNRNPR-dependent phenotypes, providing a comprehensive toolkit for research into diseases such as spinal muscular atrophy, amyotrophic lateral sclerosis, and neurodevelopmental disorders. For further information or to discuss custom applications, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)